Project Details
Description
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of VX-864 in PiZZ Subjects
| Status | Finished |
|---|---|
| Effective start/end date | 9/21/20 → 9/21/21 |
Funding
- VERTEX PHARMACEUTICALS INCORPORATED
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.